Dr. Colin Mitchell leads the Humanities team at the PHG Foundation, specializing in the legal and ethical dimensions of health technology and genomics. His expertise encompasses genomic rights and ...

In this blog, I will delve into some of the growing acceptance in healthcare to innovative approaches in various countries, and how a database will facilitate analysis and interpretation for all. The ...

HbA1c is the world’s most widely used test for diagnosing type 2 diabetes. New evidence shows that G6PD deficiency and other genetic variants are systematically distorting its results for Black and ...

Quantum computing, a type of quantum technology, is poised to address pressing challenges in the healthcare sector. For example, while the average cost of the drug development pipeline has tripled ...

The sepsis definition describes three elements: infection, the host response and life-threatening organ dysfunction. Diagnosis is made based on myriad signs and symptoms, and although infection ...

Potential fallout from the recent UK Biobank data exposure – and similar cases – highlights that governance cannot be treated as an administrative add on. It is foundational infrastructure on which ...

The PHG Foundation warmly welcomes the recently published WHO principles for human genome data collection, access, use and sharing. It is a timely and important contribution to global governance, ...

Catherine Barnard, FBA, FLSW, FRSA is Professor of European law and fellow of Trinity College, Cambridge and Director of the Centre for European Legal Studies. She is the author of EU Employment Law ...

Cost-utility studies provide critical information for the costs and benefits of using any new test, typically building on existing public health and screening programmes, within a defined population.

On Friday the High Court ruled on the case of ABC v St George’s NHS Trust (and other NHS defendants). This is a significant decision with implications for a wide range of healthcare professionals ...

The UK is a recognised powerhouse for genomic science and medicine. Genomics England’s 100,000 Genomes Project is the largest sequencing project of its kind in the world and, building on these ...

Not all patients are benefitting equally from advances in genomic research. Research databases and biobanks underpinning genetic tests and tools are full of data from populations labelled as “European ...